Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ucb ADR (UCBJY)

Ucb ADR (UCBJY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 35,437,472
  • Shares Outstanding, K 378,040
  • Annual Sales, $ 5,684 M
  • Annual Income, $ 371,230 K
  • EBIT $ 0 M
  • EBITDA $ 1,332 M
  • 60-Month Beta 0.46
  • Price/Sales N/A
  • Price/Cash Flow 23.07
  • Price/Book 3.61
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 0.663 on 05/02/13
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.7100 +8.11%
on 11/19/24
99.4000 -5.69%
on 11/08/24
+1.0250 (+1.11%)
since 10/22/24
3-Month
86.7100 +8.11%
on 11/19/24
99.4000 -5.69%
on 11/08/24
+4.1600 (+4.64%)
since 08/22/24
52-Week
36.7025 +155.40%
on 11/30/23
99.4000 -5.69%
on 11/08/24
+56.5400 (+151.99%)
since 11/22/23

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

UCB SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in providing therapy for central nervous system disorders, including epilepsy, diabetic neuropathic pain, sclerosis and Parkinson's disease. It also provides therapy in the areas of oncology, immunology, inflammation,...

See More

Key Turning Points

3rd Resistance Point 95.1927
2nd Resistance Point 94.4713
1st Resistance Point 94.1057
Last Price 93.7400
1st Support Level 93.0187
2nd Support Level 92.2973
3rd Support Level 91.9317

See More

52-Week High 99.4000
Last Price 93.7400
Fibonacci 61.8% 75.4496
Fibonacci 50% 68.0513
Fibonacci 38.2% 60.6529
52-Week Low 36.7025

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar